Advantis Corp. (OTC:ADVT) recently provided an update to shareholders, where the company provided additional details about its sublingual tabs, announced that it is completing its first orders of edible packaging, and last but not least mentioned that Amster-Can revenue is “set to double”.
What is Amster-Can Cannabis?
Amster-Can is Advantis Corp.’s premium cannabis product line that is packaged for shelf-life using the licensed and patented N2 Pack packaging process to naturally preserve the freshness of its product for up to 5 years.
Now, cannabis consumers’ favorite Indica, Sativa, and Hybrid marijuana strains, are hermetically sealed using a patented nitrogen packaging system that Advantis Corp. licensed from N2Pack Packaging Systems, LLC back in 2016.
Hermetic sealing is a process of utilizing nitrogen to replace air and moisture, thereby dramatically extending the product’s shelf life while preserving cellular integrity and sealing in the product’s natural odors.
This patented system is ideal for products with high sensitivities such as pharmaceuticals or cannabis and preserves your product’s freshness.
Edibles and Amster-Can in Growth Mode
Last week Cherry announced that the company had begun packaging edibles as well as flowers and extracts. Today, he announced that the first pallet-size orders are nearing completion this week. “The immediate demand has been amazing,” Cherry stated. “In the beginning, we were happy to go through a pallet every two to three months, today, we can go through a pallet in a week, thanks to the addition of edibles to our packaging lineup.” Cherry says that he has already ordered additional pallets for the sharp increase in demand resulting directly from the debut of edible packaging last week. “The decision to package edibles is a home run. Based on current orders, this will double Amster-Can production in the coming months, and the sublingual tabs are almost ready to go. Each new product we introduce results in a brand new scalable revenue stream to add to our bottom line,” Cherry concluded.
New Sublingual Tabs
According to Advantis CEO, Darren Cherry, the sublingual tabs will be faster acting than what is currently in the market. “Edibles and sublinguals generally take thirty to sixty minutes to take effect,” Cherry explained. “Many edibles can be more unpredictable depending on a person’s metabolism, and the amount of THC and CBD is sometimes not consistent; this makes it difficult to measure a precise dose. We have solved that problem.”
Cherry explained that the new substance delivery process will start becoming effective within two to three minutes, as opposed to the unpredictable time until efficacy with edibles and other sublingual tabs. “In addition to the delivery system, we will have precise measurements of THC, CBD, or a combination of both available in different strengths. The process is made possible by a new partnership we are cementing with a Canadian manufacturing company.”
Cherry says they are set to ink a deal with its Oregonian partner to manufacture and distribute the formula with the proprietary delivery system, and Advantis has a ready-made client base in California waiting for the tabs to arrive. The unnamed Canadian company will supply the medium and Advantis or its partners will infuse it with the exact amount of THC and/or CBD to make its end products. “We have a budding partnership in the works and can’t wait to bring these tabs to market,” Cherry said.
“Testing is underway.”
We’ll be watching shares of Advantis Corp. closely as things continue to develop. Be sure to subscribe to Advantis Corp. Updates here, or, be sure to subscribe to Cannabis Stock Updates here so you never miss an important update.
Get Real-Time Updates from MJobserver.com